Prudential Pharma's mission is to deliver health to people. That's why we're committed to developing new and safe health products. And why we are making them available and affordable for people who need them most.

The Company was founded with the mission of developing and commercializing a novel therapeutic vaccine to treat and prevent Type 1 Diabetes Mellitus (T1DM). The Company's drug is result of the many years of research by Dr. Tihamer Orban and his colleagues at the Joslin Diabetes Center aimed at gaining a better understanding of the immulogical mechanisms underlying T1DM. The Company's insulin B chain vaccine for T1DM has successfully completed a Phase I clinical trial and the drug is now poised to enter a Phase II clinical trial to evaluate dosing and metabolic effect. The Company's autoantigen based vaccine targets the root cause of T1DM: the loss of self tolerance and the resultant progressive destruction of insulin-producing beta cells. The loss of self tolerance to insulin, a primary

We are a pharmaceutical distributor for advance woundcare for diabetic ulcers and hard to heal wounds our product is the leading product available on the market. We do ship worldwide. MEDIHONEY?? dressings, a unique line of dressings containing Active Leptospermum Honey from New Zealand, possess unique qualities that make them ideal for the management of chronic and acute wounds and burns. A strong and growing evidence base ??? including several large scale randomized controlled studies ??? have shown that MEDIHONEY?? dressings are effective on hard-to-heal wounds and burns, in addition to helping to debride wounds and keeping wound beds clean of necrotic tissue.